Critical Review of the Antibacterial Pipeline

Explore a critical review of the antibacterial pipeline in this 42-minute video from the American Society for Microbiology. Delve into the World Health Organization's advisory panel analysis of 'traditional' and 'non-traditional' antibacterial agents and modulators in clinical development as of June 30, 2021. Gain insights into the WHO's role in antimicrobial resistance, examine the current state of antibacterial research, and discuss key highlights from the review. Join host Cesar Arias and distinguished guests Dr. Peter Beyer, Dr. Mark Butler, and Dr. Prabhavathi Fernandes as they dissect this crucial publication, covering topics such as methodology, pharmaceutical companies, traditional vs. non-traditional approaches, beta-lactamases, and the future of antibacterial research. Understand the challenges and controversies surrounding the development of new antibiotics and explore potential solutions for combating antimicrobial resistance.

Introduction
Methodology
Pharmaceutical Companies
Traditional vs NonTraditional
Traditional Antibiotics
Are we moving forward
Controversy
Betalactamases
Nontraditional antibacterial agents
Highlights of the manuscript
Thoughts on nontraditionals
Microbacteria
Conclusion